anti pbrm1 (Cell Signaling Technology Inc)
Structured Review
Anti Pbrm1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pbrm1/bio_rxiv__64898__2026__03__27__714789-411-2-15
Average 86 stars, based on 1 article reviews
Images
Related Articles
Incubation:Article Title: Alternative splicing of PBRM1 mediates resistance to PD-1 blockade therapy in renal cancer Article Snippet: .. For IP, cell lysates were incubated with 2 μg Article Title: Alternative splicing of PBRM1 mediates resistance to PD-1 blockade therapy in renal cancer. Article Snippet: Alternative pre-mRNA splicing (AS) is a biological process that results in proteomic diversity.. However, implications of AS alterations in cancer remain poorly understood.. Herein, we performed a comprehensive AS analysis in cancer driver gene transcripts across fifteen cancer types and found global alterations in inclusion rates of the PBAF SWI/SNF chromatin remodeling complex subunit Polybromo 1 (PBRM1) exon 27 (E27) in most types of cancer tissues compared with those in normal tissues. Western Blot:Article Title: Efficacy of CBP/p300 Dual Inhibitors against Derepression of KREMEN2 in cBAF-Deficient Cancers Article Snippet: Chemiluminescence signals were measured using a FUSION Solo S chemiluminescence imaging system (M&S Instruments) or Amersham Imager 600 (RRID: SCR_021853; Cytiva). .. Antibodies specific for the following proteins were used for immunoblotting: SMARCA4 (1:1,000, CST, 49360, RRID: AB_2728743), SMARCA2 (1:1,000, CST, 11966, RRID: AB_2797783), SMARCB1 (1:1,000, CST, 91735, RRID: AB_2800172), ARID1A (1:1,000, CST, 12354, RRID: AB_2637010), Article Title: Design, synthesis and pharmacological evaluation of new SMARCA2 degraders bearing a furo[3,2-c]pyridazine scaffold. Article Snippet: As mutually exclusive catalytic ATPase subunits of the SWI/SNF chromatin remodeling complex, SMARCA2 and SMARCA4 play crucial roles in regulating gene transcription.. Studies have revealed that SMARCA4-deficient cells exquisitely depend on SMARCA2 for survival, suggesting SMARCA2 is a promising synthetic lethal target in SMARCA4-deficient cancers.. Herein, we reported the design, synthesis, and biological evaluation of a series of novel proteolysis targeting chimeras (PROTACs) of SMARCA2 bearing a novel furo[3,2-c]pyridazine scaffold. Article Title: Efficacy of glutathione inhibitor eprenetapopt against the vulnerability of glutathione metabolism in SMARCA4-, SMARCB1- and PBRM1-deficient cancer cells Article Snippet: Chemiluminescence signals were measured using a FUSION Chemiluminescence Imaging System (M&S Instruments). .. Antibodies specific for the following proteins were used for immunoblotting: SMARCA4 (CST, 49360), SMARCB1 (CST, 91735), Article Title: Efficacy of CBP/p300 Dual Inhibitors against De-repression of KREMEN2 in cBAF-Deficient Cancers Article Snippet: 2 The SWI/SNF chromatin remodeling complex is divided into three subcomplexes: cBAF, PBAF, 35 and ncBAF.. Constituent genes (e.g., SMARCB1, SMARCA4, SMARCA2, and SS18) of the 36 SWI/SNF complex often harbor genetic abnormalities in various cancers.. Previously, we found 37 that histone acetyltransferases CBP/p300 dual inhibitors could be promising treatments for 38 SMARCB1-deficient cancers. Article Title: Alternative splicing of PBRM1 mediates resistance to PD-1 blockade therapy in renal cancer Article Snippet: .. Article Title: Efficacy of glutathione inhibitor eprenetapopt against the vulnerability of glutathione metabolism in SMARCA4-, SMARCB1- and PBRM1-deficient cancer cells. Article Snippet: Chemiluminescence signals were measured using a FUSION Chemiluminescence Imaging System (M&S Instruments). .. Antibodies specific for the following proteins were used for immunoblotting: SMARCA4 (CST, 49360), SMARCB1 (CST, 91735), Chromatin Immunoprecipitation:Article Title: Alternative splicing of PBRM1 mediates resistance to PD-1 blockade therapy in renal cancer Article Snippet: .. |
